Role of Tight Glycemic Control during Acute Coronary Syndrome on CV Outcome in Type 2 Diabetes

about

Role of Tight Glycemic Control during Acute Coronary Syndrome on CV Outcome in Type 2 Diabetes

Item

http://www.wikidata.org/entity/Q58584494

description

scientific article published on 04 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Role of Tight Glycemic Control ...... CV Outcome in Type 2 Diabetes

@en

Role of Tight Glycemic Control ...... CV Outcome in Type 2 Diabetes

@nl

type

Item

label

Role of Tight Glycemic Control ...... CV Outcome in Type 2 Diabetes

@en

Role of Tight Glycemic Control ...... CV Outcome in Type 2 Diabetes

@nl

prefLabel

Role of Tight Glycemic Control ...... CV Outcome in Type 2 Diabetes

@en

Role of Tight Glycemic Control ...... CV Outcome in Type 2 Diabetes

@nl

P1476

Role of Tight Glycemic Control ...... CV Outcome in Type 2 Diabetes

@en

P2093

Aldo Marrone

http://www.w3.org/2001/XMLSchema#string

Luigi Elio Adinolfi

http://www.w3.org/2001/XMLSchema#string

Nadia Lascar

http://www.w3.org/2001/XMLSchema#string

Raffaele Marfella

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Coronary artery revascularization in patients with diabetes mellitus

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Intensive insulin therapy and pentastarch resuscitation in severe sepsis

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Effects of intensive glucose lowering in type 2 diabetes

10-year follow-up of intensive glucose control in type 2 diabetes

Glucose control and vascular complications in veterans with type 2 diabetes

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

P304

3106056

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2018/3106056

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

Ferdinando Carlo Sasso

Pia Clara Pafundi

Luca Rinaldi

P5008

ScienceSource

P577

2018-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30402502

http://www.w3.org/2001/XMLSchema#string

P921

Angliavandeniai

endocrinology

type-2 diabetes

maturity-onset diabetes of the young

P932

6193345

http://www.w3.org/2001/XMLSchema#string